drug
product
contain
antibodi
ab
deriv
activ
ingredi
success
use
prevent
treatment
sever
social
signific
diseas
cancer
multipl
sclerosi
influenza
acut
respiratori
tract
viral
infect
diabet
etc
principl
interact
underli
therapeut
effect
medicin
antigenantibodi
agab
interact
identif
quantif
therefor
import
target
immunoassay
date
varieti
correspond
assay
avail
differ
method
detect
interact
direct
detect
agab
complex
identifi
either
visual
simpl
optic
devic
detect
base
passiv
agglutin
reaction
ie
adhes
particl
ag
ab
bound
surfac
detect
reli
use
variou
label
detect
techniqu
employ
rapid
portabl
highsensit
sensor
latter
includ
immunochromatograph
system
immunochip
immunosensor
repres
fastdevelop
approach
laboratori
analysi
use
variou
type
biolog
sensit
element
furnish
inform
agab
interact
form
electr
signal
import
distinct
immunosensor
assay
method
signal
transduct
may
employ
either
electrochem
optic
transduc
electrochem
transduc
electrochem
signal
measur
magnitud
chang
follow
format
agab
complex
case
optic
transduc
agab
quantif
base
gener
light
signal
color
chang
fluoresc
chang
optic
properti
environ
among
major
advantag
immunosensor
rapid
analysi
conveni
use
possibl
quantif
subsequ
mathemat
process
portabl
test
devic
high
sensit
one
promis
biosensor
option
piezoelectr
immunosensor
pi
design
basi
quartz
crystal
reson
qcr
intend
detect
bacteria
identif
biolog
nanoparticl
registr
immun
interact
pi
enabl
direct
detect
biochem
interact
receptor
molecul
without
need
addit
label
fluoresc
enzymat
etc
favor
distinguish
similar
devic
type
immunosensor
character
fast
respons
eas
oper
integr
multisensori
system
automat
data
acquisit
system
unparallel
featur
pi
compromis
high
sensit
ensur
use
qcr
transduc
element
select
determin
specif
receptor
molecul
employ
principl
behind
pi
oper
detect
frequenc
variat
electr
signal
follow
agab
complex
format
result
increas
mass
sens
quartz
plate
reson
cantilev
specif
biolay
qcr
provid
highli
select
identif
homolog
antigen
complex
mixtur
need
addit
procedur
involv
reagent
work
aim
demonstr
possibl
use
pi
effici
tool
tackl
novel
task
particular
associ
analyz
effect
releasedact
form
ab
interferongamma
raf
ab
ifng
immun
interact
molecular
level
releasedact
ra
phenomenon
discov
studi
process
techniqu
involv
repeat
serial
step
decreas
concentr
initi
substanc
combin
extern
treatment
step
dilut
prepar
use
techniqu
found
share
common
featureth
abil
directli
modifi
initi
substanc
alter
spatial
structur
consequ
physicochem
biolog
properti
rafbas
drug
product
refer
releasedact
efficaci
safeti
proven
nonclin
clinic
studi
also
previous
demonstr
possibl
use
elisa
test
examin
effect
antibodi
nonantibodi
raf
agab
interact
develop
studi
raf
ab
ifng
use
elisa
show
bind
constant
commerci
ab
ifng
chang
presenc
raf
ab
ifng
indic
raf
ab
ifng
influenc
steric
interact
characterist
pi
larg
depend
concentr
steric
avail
biomolecul
immobil
onto
electrod
surfac
suggest
approach
could
use
identif
test
assay
raf
ab
purpos
select
pi
techniqu
employ
highsensit
sensor
order
evalu
effect
raf
ab
ifng
agab
interact
provid
us
data
elucid
influenc
raf
ab
ab
affin
ifng
find
present
paper
studi
piezoelectr
immunosensor
use
detect
absag
interact
ab
ifng
ifng
presenc
raf
ab
ifng
control
sampl
physic
transduc
highfrequ
piezoelectr
atcut
quartz
crystal
reson
use
oper
bulk
acoust
wave
baw
principl
reson
occur
across
entir
mass
crystal
devic
oper
frequenc
hz
base
gold
nanoparticl
assembl
onto
mm
diamet
electrod
provid
activ
site
immobil
ab
molecul
zao
ethna
moscow
russia
variat
oscil
frequenc
quartz
crystal
reson
analyt
signal
piezoelectr
immunosensor
paramet
depend
increas
decreas
mass
bioreceptor
mass
chang
aris
format
disintegr
immun
complex
sensor
surfac
analysi
liquid
use
piezoelectr
sensor
carri
static
flow
mode
first
case
procedur
known
dip
dri
increas
receptor
layer
mass
measur
contact
sensor
analyz
liquid
sampl
airdri
constant
mass
wherea
second
case
flow
mode
signal
sensor
measur
continu
test
sampl
analyz
flow
mode
use
sensor
detector
flowinject
analysi
make
possibl
rais
speed
determin
also
provid
opportun
observ
immunochem
reaction
real
time
analysi
employ
dosag
unit
sampl
power
unit
flow
cell
provid
contact
analyz
sampl
one
end
sensor
peristalt
pump
knauer
berlin
germani
drive
circuit
ttl
base
transform
mass
chang
bioreceptor
coat
frequenc
fluctuat
frequencymeasur
devic
discop
npp
bafika
moscow
russia
person
comput
test
perform
use
surfac
coat
electrod
oscil
frequenc
record
everi
liquid
sampl
util
without
prior
prepar
lactos
tablet
sampl
amount
mg
dissolv
ml
distil
water
room
temperatur
tablet
initi
ground
use
porcelain
mortar
pestl
dissolut
heat
min
follow
centrifug
rpm
min
sampl
type
combin
ifng
sampl
ifng
ratio
incub
min
follow
centrifug
rpm
min
measur
analyt
signal
sampl
result
obtain
process
analyt
signal
record
experiment
five
read
three
oper
engag
total
read
raf
ab
ifng
suppli
test
form
readytous
solut
tablet
lactos
powder
ooo
npf
materia
medica
hold
moscow
russia
affin
purifi
polyclon
rabbit
antibodi
recombin
human
ifng
manufactur
angel
biotechnolog
hold
plc
edinburgh
uk
start
materi
commerci
product
oral
therapeut
anaferon
children
accord
current
european
union
gmp
requir
start
materi
raf
ab
ifng
obtain
use
routin
method
describ
european
pharmacopoeia
briefli
antibodi
ifng
mgml
mix
solvent
ethanolwat
solut
shaken
min
produc
dilut
first
centesim
dilut
subsequ
dilut
compris
one
part
previou
dilut
part
solvent
ethanolwat
solut
intermedi
dilut
distil
water
prepar
final
dilut
success
dilut
step
thu
raf
ab
ifng
contain
releasedact
dilut
antibodi
dilut
receiv
mixtur
final
dilut
solut
prepar
steril
condit
protect
direct
intens
light
store
room
temperatur
dilut
prepar
glass
vial
lactos
sampl
prepar
lactos
monohydr
powder
satur
raf
ab
ifng
l
pilotlab
fluid
bed
apparatu
gmbh
schopfheim
germani
case
tablet
form
tablet
made
lactos
powder
satur
raf
ab
ifng
auxiliari
compon
compress
mold
case
placebo
solvent
buffer
solut
equival
vehicl
ab
ifng
use
prepar
raf
buffer
raf
b
instead
ab
ifng
follow
method
describ
solut
raf
b
use
prepar
lactos
tablet
placebo
sampl
raf
nonspecif
control
prepar
similarli
raf
ab
ifng
use
ab
tumor
necrosi
factor
alpha
tnfa
sigmaaldrich
st
loui
mo
usa
diclofenac
sodium
salt
sigmaaldrich
st
loui
mo
usa
respect
start
materi
instead
ab
ifng
raf
ab
ifng
placebo
nonspecif
control
code
manufactur
examin
blind
studi
standard
ifng
solut
prepar
dissolv
ifng
abcam
cambridg
uk
ml
bidistil
water
antibodi
compon
repres
affin
purifi
polyclon
rabbit
ab
human
ifng
ucytech
bioscienc
bv
utrecht
netherland
concentr
ngml
work
solut
ab
ifng
prepar
without
perform
dilut
dilut
two
four
eight
time
phosphatebuff
salin
pb
contain
gl
nacl
kcl
na
hpo
kh
po
follow
organ
solvent
use
dimethylformamid
dmfa
aceton
estev
quimica
spain
methanol
ethanol
chloroform
reachem
moscow
russia
nonorgan
reagent
includ
hydrochlor
acid
sodium
chlorid
sodium
hydrophosph
sodium
tetrabor
sodium
azid
potassium
chlorid
potassium
dihydrophosph
potassium
thiocyan
ammonium
sulfat
reachem
moscow
russia
crosslink
reagent
use
follow
glutaraldehyd
ga
carbodiimid
edac
n
n
dicyclohexylcarbodiimid
dcc
nhydroxysuccinimid
nh
cystamin
reanal
budapest
hungari
follow
reagent
use
regener
agent
potassium
rhodanid
hydroxylamin
hydrochlorid
carbamid
phenol
diethylamin
hydrochlorid
magnesium
chlorid
differ
concentr
bidistil
water
reachem
moscow
russia
compound
util
prepar
thinlay
substrat
includ
electrod
coat
substrat
materi
ab
ifng
solut
concentr
ngml
ngml
ngml
ngml
adsorb
deposit
ifng
solut
onto
substrat
signal
record
five
method
ab
adsorpt
chosen
adsorpt
ab
ifng
immobil
onto
aptscoat
substrat
edac
ga
use
crosslink
siloxan
layer
apt
spotcoat
onto
surfac
microsyring
min
follow
addit
ga
solut
bidistil
water
edac
solut
acetonitril
altern
method
gold
electrod
coat
acid
solut
ethanol
incub
h
thereaft
electrod
surfac
rins
ethanol
edac
solut
acetonitril
nh
mm
solut
ethanol
ad
follow
incub
incub
treat
electrod
rins
pb
anoth
ab
adsorpt
techniqu
involv
coat
sensor
surfac
incub
room
temperatur
min
follow
ga
solut
bidistil
water
deposit
subsequ
incub
h
pb
rins
next
method
mu
ombp
mpt
amt
success
coat
onto
freshli
clean
electrod
surfac
incub
dri
oven
h
thereaft
freshli
prepar
glutaraldehyd
ad
min
sensor
care
rins
buffer
final
method
sensor
surfac
coat
incub
room
temperatur
min
surfac
activ
deposit
ga
solut
bidistil
water
subsequ
incub
h
buffer
rins
calix
aren
follow
incub
buffer
rins
analyt
signal
measur
perform
flowinject
mode
flow
rate
pb
regener
receptor
layer
carri
could
reus
follow
chang
analyt
signal
chaotrop
agent
pass
sensor
surfac
result
dissoci
heterogen
ifngab
affin
complex
allow
avoid
destruct
substrat
differ
solut
concentr
potassium
rhodanid
hydroxylamin
hydrochlorid
urea
phenol
diethylamin
hydrochlorid
magnesium
chlorid
differ
concentr
well
bidistil
water
test
regener
agent
stabil
durat
pi
oper
evalu
number
n
measur
run
analyt
signal
decreas
data
process
statist
analysi
perform
use
statist
softwar
data
analysi
main
part
experi
carri
use
oneway
analysi
varianc
anova
test
repeat
assess
use
gaug
repeat
reproduc
analysi
grr
test
seri
chaotrop
agent
potenti
use
regener
agent
requir
statist
analysi
data
present
group
deviat
unless
indic
otherwis
pvalu
regard
statist
signific
initi
experiment
stage
includ
studi
defin
condit
receptor
layer
format
provid
enhanc
analyt
signal
stage
includ
select
coat
treatment
regener
agent
sampl
antigen
ratio
five
differ
coat
treatment
examin
see
experiment
section
show
optim
properti
consid
cost
coat
magnitud
analyt
signal
ensur
treatment
employ
activ
glutaraldehyd
studi
examin
differ
ab
concentr
maximum
signal
magnitud
observ
ngml
ab
sampl
differ
analyt
signal
obtain
differ
coat
treatment
present
supplementari
tabl
allow
repeat
use
receptor
layer
regener
chaotrop
solut
perform
follow
analyt
signal
measur
result
dissoci
heterogen
ifngab
affin
complex
without
substrat
destruct
solut
potassium
rhodanid
diethylamin
hydroxylamin
hydrochlorid
demonstr
effect
regener
agent
ensur
fast
regener
sensor
durabl
supplementari
tabl
quantif
effect
test
sampl
specif
ifngab
interact
necessari
defin
proper
sampl
ifng
ratio
greatest
differ
obtain
sampl
ifng
ratio
employ
test
repeat
studi
involv
test
ratio
best
result
obtain
result
present
due
data
abund
way
condit
pi
measur
select
base
data
provid
studi
describ
main
experiment
part
aim
test
raf
sampl
use
develop
test
procedur
defin
condit
sinc
analyt
signal
shown
diminish
presenc
raf
ab
ifng
reliabl
result
ab
human
ifng
detect
expect
regard
indirect
measur
compar
analyt
signal
sensor
obtain
ifng
solut
contain
contain
raf
specif
ab
consid
avail
elisa
suggest
effect
raf
ab
ifng
could
evalu
use
preincub
one
compon
agab
system
compound
contain
raf
ab
ifng
howev
variat
analyt
signal
measur
pi
may
occur
result
specif
ifngab
interact
also
due
dilut
ionic
strength
chang
analyz
solut
nonspecif
interact
secondari
compon
ifng
receptor
layer
henc
presenc
raf
ab
ifng
sampl
demonstr
higher
reliabl
differenti
evalu
signal
undertaken
account
nois
signal
examin
differ
signal
obtain
presenc
raf
ab
ifng
placebo
evalu
describ
carri
show
analyt
signal
decreas
follow
preincub
ab
ifng
raf
ab
ifng
indic
attenu
affin
ifng
specif
ab
presenc
raf
ab
ifng
instanc
decreas
analyt
signal
greater
raf
ab
ifng
compar
placebo
differ
signal
magnitud
p
tablet
p
liquid
sampl
lactos
powder
figur
ab
ifng
howev
variat
analyt
signal
measur
pi
may
occur
result
specif
ifngab
interact
also
due
dilut
ionic
strength
chang
analyz
solut
nonspecif
interact
secondari
compon
ifng
receptor
layer
henc
presenc
raf
ab
ifng
sampl
demonstr
higher
reliabl
differenti
evalu
signal
undertaken
account
nois
signal
examin
differ
signal
obtain
presenc
raf
ab
ifng
placebo
evalu
describ
carri
show
analyt
signal
decreas
follow
preincub
ab
ifng
raf
ab
ifng
indic
attenu
affin
ifng
specif
ab
presenc
raf
ab
ifng
instanc
decreas
analyt
signal
greater
raf
ab
ifng
compar
placebo
differ
signal
magnitud
p
tablet
p
liquid
sampl
lactos
powder
figur
repeat
intraassay
precis
evalu
mean
analyt
signal
valu
supplementari
tabl
use
ratio
sampl
ifng
data
present
control
test
sampl
oscil
frequenc
sensor
follow
absifng
bind
hz
standard
deviat
confidenti
interv
valu
indic
tabl
repeat
paramet
determin
precis
net
signal
measur
perform
short
time
period
ab
ifng
detect
liquid
sampl
lactos
sampl
tablet
obtain
valu
reflect
high
degre
repeat
figur
intermedi
precis
analyt
signal
test
sampl
differ
raf
ab
ifng
green
vs
control
grey
measur
three
oper
period
n
p
full
data
present
supplementari
tabl
mean
pr
f
repeat
intraassay
precis
evalu
mean
analyt
signal
valu
supplementari
tabl
use
ratio
sampl
ifng
data
present
control
test
sampl
oscil
frequenc
sensor
follow
absifng
bind
hz
standard
deviat
confidenti
interv
valu
indic
tabl
repeat
paramet
determin
precis
net
signal
measur
perform
short
time
period
ab
ifng
detect
liquid
sampl
lactos
sampl
tablet
obtain
valu
reflect
high
degre
repeat
evalu
intermedi
precis
perform
term
singl
studi
examin
analyt
result
obtain
differ
oper
total
measur
rel
standard
deviat
approxim
water
solut
lactos
powder
tablet
point
high
close
result
obtain
differ
oper
differ
day
mean
valu
therefor
high
procedur
reproduc
figur
supplementari
tabl
specif
analyt
procedur
develop
test
use
follow
nonspecif
control
raf
ab
tnfa
raf
diclofenacin
form
tablet
solut
nonspecif
lactos
control
unavail
use
test
oppos
raf
ab
ifng
differ
signal
magnitud
nonspecif
control
raf
ab
tnfa
raf
diclofenac
compar
placebo
rang
henc
raf
ab
ifng
capabl
specif
interf
agab
bind
figur
ppraf
ab
pcontrolq
p
detect
raf
ab
challeng
develop
class
drug
appropri
method
determin
raf
ab
activ
base
mechan
action
sensit
enough
detect
small
chang
interact
molecul
state
raf
ab
exert
direct
effect
conform
paramet
biolog
target
molecul
probabl
trigger
mechan
result
sensit
biolog
target
modif
paramet
ligandreceptor
antigenantibodi
interact
pi
approach
seem
conveni
solv
kind
task
result
confirm
suggest
show
pi
devic
applic
detect
raf
ab
ifng
sampl
formul
solut
lactos
powder
tablet
examin
effect
interact
ifng
specif
ab
evalu
intermedi
precis
perform
term
singl
studi
examin
analyt
result
obtain
differ
oper
total
measur
rel
standard
deviat
approxim
water
solut
lactos
powder
tablet
point
high
close
result
obtain
differ
oper
differ
day
mean
valu
therefor
high
procedur
reproduc
figur
supplementari
tabl
specif
analyt
procedur
develop
test
use
follow
nonspecif
control
raf
ab
tnfa
raf
diclofenacin
form
tablet
solut
nonspecif
lactos
control
unavail
use
test
oppos
raf
ab
ifng
differ
signal
magnitud
nonspecif
control
raf
ab
tnfa
raf
diclofenac
compar
placebo
rang
henc
raf
ab
ifng
capabl
specif
interf
agab
bind
figur
raf
ab
ifng
control
control
mean
p
detect
raf
ab
challeng
develop
class
drug
appropri
method
determin
raf
ab
activ
base
mechan
action
sensit
enough
detect
small
chang
interact
molecul
state
raf
ab
exert
direct
effect
conform
paramet
biolog
target
molecul
probabl
trigger
mechan
result
sensit
biolog
target
modif
paramet
ligandreceptor
antigenantibodi
interact
pi
approach
seem
conveni
solv
kind
task
result
confirm
suggest
show
pi
devic
applic
detect
raf
ab
ifng
sampl
formul
solut
lactos
powder
tablet
examin
effect
interact
ifng
specif
ab
method
develop
preliminari
test
stage
includ
perform
analysi
experiment
condit
involv
select
optim
coat
electrod
surfac
detect
condit
proper
chaotrop
agent
electrod
regener
addit
analyt
signal
obtain
experi
low
rel
deviat
shortterm
measur
test
repeat
differ
day
differ
oper
suggest
high
repeat
intermedi
precis
analyt
procedur
piezoelectr
sensor
techniqu
shown
high
specif
allow
specif
identif
raf
ab
ifng
sampl
comparison
control
method
develop
preliminari
test
stage
includ
perform
analysi
experiment
condit
involv
select
optim
coat
electrod
surfac
detect
condit
proper
chaotrop
agent
electrod
regener
addit
analyt
signal
obtain
experi
low
rel
deviat
shortterm
measur
test
repeat
differ
day
differ
oper
suggest
high
repeat
intermedi
precis
analyt
procedur
piezoelectr
sensor
techniqu
shown
high
specif
allow
specif
identif
raf
ab
ifng
sampl
comparison
control
thu
develop
assay
could
use
regular
detect
ifngantibodi
ifng
interact
identif
raf
ab
ifng
solut
lactos
powder
tablet
sampl
comparison
control
establish
techniqu
reliabl
reproduc
easi
perform
obtain
data
support
find
receiv
elisa
method
develop
show
abil
raf
ab
ifng
modifi
ifng
affin
specif
ab
ifng
encourag
assumpt
raf
ab
effect
spatial
agab
interact
nevertheless
studi
field
contempl
supplementari
materi
follow
avail
onlin
http
tabl
studi
affin
biolay
coat
obtain
use
variou
prepar
method
differ
ab
concentr
tabl
effect
differ
chaotrop
agent
number
measur
run
n
mu
use
receptor
layer
coat
tabl
repeat
evalu
net
signal
measur
target
sampl
vs
refer
solut
full
data
tabl
intermedi
precis
evalu
net
signal
measur
target
sampl
vs
refer
solut
n
p
full
data
